Trevi Therapeutics, Inc. (TRVI)
14.04
-0.22
(-1.54%)
USD |
NASDAQ |
May 07, 16:00
14.04
0.00 (0.00%)
After-Hours: 20:00
Trevi Therapeutics SG&A Expense (TTM) : 12.19M for March 31, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Gilead Sciences, Inc. | 8.398B |
| Puma Biotechnology, Inc. | 70.85M |
| Terns Pharmaceuticals, Inc. | 32.24M |
| ACADIA Pharmaceuticals, Inc. | 548.89M |
| Alnylam Pharmaceuticals, Inc. | 1.293B |